Rochester neuroscience company Cognivue Inc. has begun a nationwide clinical study to assess post-COVID-19 Syndrome. COG-COVID19 is an open-label, prospective, two-armed comparison clinical study to assess the impact of COVID-19 on cognitive function. Researchers from the University of Southern California, ...
Tagged with: cognitive function cognivue covid
Read More »